Alpelisib Market Analysis by Product Type (Piqray, Vijoyce), by Application (Oncology, Breast cancer, Postmenopause, Others), by Distribution Channel (Drug Stores, Mail Order Pharmacies, Online) and by Region: Global Forecast, 2024 - 2034

  • 2024-05-02
  • 191
  • Healthcare & Life Sciences

Market Overview

The Alpelisib market is predicted to develop at a compound annual growth rate (CAGR) of XX% from 2024 to 2034, when it is projected to reach USD XX Million, based on an average growth pattern. The market is estimated to reach a value of USD XX Million in 2024.


SOURCE: We Market Research

Alebrisib is one medication that is used to treat several diseases, most notably advanced breast cancer. The substance originates from a class of drugs known as PI3K inhibitors, which work by blocking a specific pathway that promotes the growth and spread of cancer cells. Alpelisib, a phospholipase 3-kinase (PI3K) inhibitor, exhibits potent anticancer properties. It works by selectively inhibiting the catalytic subunit of PI3K, class I PI3K p110α, a lipid kinase implicated in numerous biological processes like survival, proliferation, differentiation, and metabolism. This enzyme, which appears to be hyperactivated due to mutations at a rate of about 30% in human malignancies, is the precise target of the drug alepelisib.

The FDA approved alpelisib on May 24, 2019. The FDA approved the use of alepelisib in April 2022 for the treatment of adults and children with PIK3CA-Related Overgrowth Spectrum (PROS) who need systemic therapy. The global market for aleplisib is being driven by advancements in precision medicine, an increasing number of cancer cases worldwide, and an increasing frequency of cancers with PIK3CA mutations. The positive clinical efficacy and safety properties of combination medications enable their use. Increasing access to healthcare and funding for oncology research are two further reasons propelling market rise. Alepelisib's adoption and positioning as a crucial element of targeted therapy for specific cancer types, such breast cancer, mostly relies on commercial expansion strategies and regulatory clearances. 

Market Scope

Report Attributes


Market Size in 2024

USD XX Million

Market Forecast in 2034

USD XX Million

CAGR % 2024-2034


Base Year


Historic Data


Forecast Period


Report USP


Production, Consumption, company share, company heatmap, company production capacity, growth factors and more

Segments Covered

by Product Type, by Application, by Distribution Channel and By Region

Regional Scope

North America, Europe, APAC, South America and Middle East and Africa

Country Scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia; Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria


Alpelisib Industry: Dynamics & Restrains

 Market opportunity:


 We Market Research: Alpelisib Dashboard

Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.

Alpelisib Segmentation

Market- By Product Type Analysis

By Product Type, the Alpelisib Market is Categories into Piqray, Vijoyce. The Piqray segment accounts for the largest share of around 92% in 2024.

The drug created by Novartis, known by the brand name Piqray (Alpelisib), is well-known and used to treat metastatic breast cancer with PIK3CA mutations that is hormone receptor (HR)-positive but HER2-negative.

The following segments are part of an in-depth analysis of the global Alpelisib market:

Market Segments


By   Application

·         Oncology

·         Breast cancer

·         Postmenopause

·         Others

By  Distribution Channel

·         Drug Stores

·         Mail Order Pharmacies

·         Online


Alpelisib Industry: Regional Analysis

North America Market Forecast

North America dominate the Alpelisib Market with the highest revenue generating market with share of more than 48%. Strong R&D spending, a high rate of breast cancer, and a sophisticated healthcare system are the primary drivers of the Alpelisib market in North America, particularly in the US. Advantageous reimbursement practices and early uptake of novel medications also contribute to market growth.

Europe Market Statistics

Europe is the second largest market in Alpelisib market. The growing awareness of personalized medications and precision medicine is helping Alpelisib's market share in Europe. In countries like Germany, France, and the UK, market expansion is facilitated by substantial government programs that pay for cancer treatment and large healthcare expenditures.

Asia Pacific Market Forecasts

Asia Pacific is expected to be the fastest-growing regional segment of the Alpelisib market during the forecast period. The Asia Pacific area is witnessing rapid market growth because of an extensive patient pool, increasing disposable income, and better healthcare facilities. Important regions like China and India are seeing expansion due to rising cancer incidence rates and improved access to cutting-edge therapies.

Key Market Players

The Alpelisib Market is dominated by a few large companies, such as

·         Novartis AG

·         Other

1.      Global Alpelisib Market Introduction and Market Overview

1.1.    Objectives of the Study

1.2.    Global Alpelisib Market Scope and Market Estimation

1.2.1. Global Alpelisib Overall Market Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 - 2034)

1.2.2. Global Alpelisib Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2034

1.3.    Market Segmentation

1.3.1. Component of Global Alpelisib Market

1.3.2. Technology of Global Alpelisib Market

1.3.3. Distribution Channel of Global Alpelisib Market

1.3.4. Region of Global Alpelisib Market

2.      Executive Summary

2.1.    Global Alpelisib Market Industry Trends under COVID-19 Outbreak

2.1.1. Global COVID-19 Status Overview

2.1.2. Influence of COVID-19 Outbreak on Global Alpelisib Market Industry Development

2.2.    Market Dynamics

2.2.1. Drivers

2.2.2. Limitations

2.2.3. Opportunities

2.2.4. Impact Analysis of Drivers and Restraints

2.3.    Pricing Trends Analysis & Average Selling Prices (ASPs)

2.4.    Key Mergers & Acquisitions, Expansions, JVs, Funding / VCs, etc.

2.5.    Porter’s Five Forces Analysis

2.5.1. Bargaining Power of Suppliers

2.5.2. Bargaining Power of Buyers

2.5.3. Threat of Substitutes

2.5.4. Threat of New Entrants

2.5.5. Competitive Rivalry

2.6.    Value Chain / Ecosystem Analysis

2.7.    Russia-Ukraine War Impacts Analysis

2.8.    Economic Downturn Analysis

2.9.      Market Investment Opportunity Analysis (Top Investment Pockets), By Segments & By Region

3.      Global Alpelisib Market Estimates & Historical Trend Analysis (2019 - 2023)

4.      Global Alpelisib Market Estimates & Forecast Trend Analysis, by PRODUCT TYPE

4.1.    Global Alpelisib Market Revenue (US$ Mn) Estimates and Forecasts, by PRODUCT TYPE, 2019 to 2034

4.1.1. Piqray

4.1.2. Vijoyce

5.      Global Alpelisib Market Estimates & Forecast Trend Analysis, by Application

5.1.    Global Alpelisib Market Revenue (US$ Mn) Estimates and Forecasts, by Application, 2019 to 2034

5.1.1. Oncology

5.1.2. Breast cancer

5.1.3. Postmenopause

5.1.4. Others

6.      Global Alpelisib Market Estimates & Forecast Trend Analysis, by Distribution Channel

6.1.    Global Alpelisib Market Revenue (US$ Mn) Estimates and Forecasts, by Distribution Channel, 2019 to 2034

6.1.1. Drug Stores

6.1.2. Mail Order Pharmacies

6.1.3. Online

7.      Global Alpelisib Market Estimates & Forecast Trend Analysis, by Region

7.1.    Global Alpelisib Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2019 to 2034

7.1.1. North America

7.1.2. Europe

7.1.3. Asia Pacific

7.1.4. Middle East & Africa

7.1.5. South America

8.      North America Alpelisib Market: Estimates & Forecast Trend Analysis

8.1.    North America Alpelisib Market Assessments & Key Findings

8.1.1. North America Alpelisib Market Introduction

8.1.2. North America Alpelisib Market Size Estimates and Forecast (US$ Million) (2019 – 2034)   By PRODUCT TYPE   By Application   By Distribution Channel   By Country     The U.S.     Canada     Mexico

9.      Europe Alpelisib Market: Estimates & Forecast Trend Analysis

9.1.    Europe Alpelisib Market Assessments & Key Findings

9.1.1. Europe Alpelisib Market Introduction

9.1.2. Europe Alpelisib Market Size Estimates and Forecast (US$ Million) (2019 – 2034)   By PRODUCT TYPE   By Application   By Distribution Channel        By Country     Germany     U.K.     France     Italy     Spain     Russia     Rest of Europe

10.  Asia Pacific Alpelisib Market: Estimates & Forecast Trend Analysis

10.1.  Asia Pacific Market Assessments & Key Findings

10.1.1.   Asia Pacific Alpelisib Market Introduction

10.1.2.   Asia Pacific Alpelisib Market Size Estimates and Forecast (US$ Million) (2019 – 2034)    By PRODUCT TYPE    By Application    By Distribution Channel    By Country China Japan India Australia South Korea ASEAN Rest of Asia Pacific

11.  Middle East & Africa Alpelisib Market: Estimates & Forecast Trend Analysis

11.1.  Middle East & Africa Market Assessments & Key Findings

11.1.1.   Middle East & Africa Alpelisib Market Introduction

11.1.2.   Middle East & Africa Alpelisib Market Size Estimates and Forecast (US$ Million) (2019 – 2034)    By PRODUCT TYPE    By Application    By Distribution Channel    By Country U.A.E. Saudi Arabia Egypt South Africa Rest of Middle East & Africa

12.  South America Alpelisib Market: Estimates & Forecast Trend Analysis

12.1.  South America Market Assessments & Key Findings

12.1.1.   South America Alpelisib Market Introduction

12.1.2.   South America Alpelisib Market Size Estimates and Forecast (US$ Million) (2019 – 2034)    By PRODUCT TYPE    By Application    By Distribution Channel    By Country Brazil Argentina Colombia Rest of South America

13.  Competition Landscape

13.1.  Global Alpelisib Market Competition Matrix & Benchmarking, by Leading Players / Innovators / Emerging Players / New Entrants

13.2.  Global Alpelisib Market Competition White Space Analysis, By Distribution Channel

13.3.  Global Alpelisib Market Competition Heat Map Analysis, By Distribution Channel

13.4.  Global Alpelisib Market Concentration & Company Market Shares (%) Analysis, 2022

14.  Company Profiles

14.1.                     Novartis AG.

14.1.1.   Company Overview & Key Stats

14.1.2.   Financial Performance & KPIs

14.1.3.   Product Portfolio

14.1.4.   Business Strategy & Recent Developments

* Similar details would be provided for all the players mentioned below 

14.2.      Others

15.  Research Methodology

15.1.  External Transportations / Databases

15.2.  Internal Proprietary Database

15.3.  Primary Research

15.4.  Secondary Research

15.5.  Assumptions

15.6.  Limitations

15.7.  Report FAQs

16.  Research Findings & Conclusion

Quality Assurance Process

  1. We Market Research’s Quality Assurance program strives to deliver superior value to our clients.

We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.

Market Research Process

We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.

To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
  • Project kickoff meeting with client
  • Conduct frequent client communications
  • Form project steering committee
  • Assign a senior SR executive as QA Executive
  • Conduct internal editorial & quality reviews of project deliverables
  • Certify project staff in SR methodologies & standards
  • Monitor client satisfaction
  • Monitor realized value post-project

Case Study- Automotive Sector

One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).


The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research

The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.

Market Estimates and Forecast

In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.

Case Study- ICT Sector

Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.

Business Solution

An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.


The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.

Frequently Asked Questions

What is the market size of Alpelisib Market in 2024?

Alpelisib Market was valued at USD XX Million in 2024.

What is the growth rate for the Alpelisib Market?

Alpelisib Market size will increase at approximate CAGR of XX% during the forecasted period.

Which are the top companies operating within the market?

Major companies operating within the Alpelisib Market Are Novartis AG and Other.

Which region dominates the Alpelisib Market?

North America dominates the market with an active share of 48%.


Select a license type that suits your business needs

Single User Access

US $3750

Only Three Thousand Seven Hundred Fifty US dollar

  • 1 User access
  • 15% Additional Free Customization
  • Free Unlimited post-sale support
  • 100% Service Guarantee until achievement of ROI
Multi User Cost

US $4750

Only Four Thousand Seven Hundred Fifty US dollar

  • 5 Users access
  • 25% Additional Free Customization
  • Access Report summaries for Free
  • Guaranteed service
  • Dedicated Account Manager
  • Discount of 20% on next purchase
  • Get personalized market brief from Lead Author
  • Printing of Report permitted
  • Discount of 20% on next purchase
  • 100% Service Guarantee until achievement of ROI
Enterprise User Cost

US $5750

Only Five Thousand Seven Hundred Fifty US dollar

  • Unlimited User Access
  • 30% Additional Free Customization
  • Exclusive Previews to latest or upcoming reports
  • Discount of 30% on next purchase
  • 100% Service Guarantee until achievement of ROI